Morgan Stanley’s AMAG Pharmaceuticals, Inc. AMAG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2020
Q4
Sell
-605,625
Closed -$5.69M 7252
2020
Q3
$5.69M Buy
605,625
+207,066
+52% +$1.95M ﹤0.01% 2590
2020
Q2
$3.05M Buy
398,559
+307,695
+339% +$2.35M ﹤0.01% 3175
2020
Q1
$560K Sell
90,864
-498,770
-85% -$3.07M ﹤0.01% 4315
2019
Q4
$7.18M Buy
589,634
+396,887
+206% +$4.83M ﹤0.01% 2792
2019
Q3
$2.23M Sell
192,747
-188,820
-49% -$2.18M ﹤0.01% 3682
2019
Q2
$3.81M Buy
381,567
+356,826
+1,442% +$3.56M ﹤0.01% 3209
2019
Q1
$319K Sell
24,741
-38,431
-61% -$496K ﹤0.01% 4814
2018
Q4
$960K Sell
63,172
-39,193
-38% -$596K ﹤0.01% 4308
2018
Q3
$2.05M Sell
102,365
-1,148
-1% -$23K ﹤0.01% 3979
2018
Q2
$2.02M Sell
103,513
-9,233
-8% -$180K ﹤0.01% 4072
2018
Q1
$2.27M Sell
112,746
-16,558
-13% -$334K ﹤0.01% 3887
2017
Q4
$1.71M Sell
129,304
-443,802
-77% -$5.88M ﹤0.01% 4151
2017
Q3
$10.6M Sell
573,106
-155,907
-21% -$2.88M ﹤0.01% 2214
2017
Q2
$13.4M Sell
729,013
-279,862
-28% -$5.15M ﹤0.01% 1887
2017
Q1
$22.8M Sell
1,008,875
-4,038
-0.4% -$91.1K 0.01% 1446
2016
Q4
$35.2M Sell
1,012,913
-14,760
-1% -$514K 0.01% 1091
2016
Q3
$25.2M Buy
1,027,673
+52,098
+5% +$1.28M 0.01% 1289
2016
Q2
$23.3M Buy
975,575
+589,567
+153% +$14.1M 0.01% 1304
2016
Q1
$9.03M Buy
386,008
+193,210
+100% +$4.52M ﹤0.01% 1936
2015
Q4
$5.82M Sell
192,798
-309,663
-62% -$9.35M ﹤0.01% 2518
2015
Q3
$20M Buy
502,461
+321,130
+177% +$12.8M 0.01% 1374
2015
Q2
$12.5M Buy
181,331
+56,328
+45% +$3.89M ﹤0.01% 1890
2015
Q1
$6.83M Sell
125,003
-184,960
-60% -$10.1M ﹤0.01% 2448
2014
Q4
$13.2M Sell
309,963
-77,011
-20% -$3.28M ﹤0.01% 1807
2014
Q3
$12.3M Sell
386,974
-257,319
-40% -$8.21M ﹤0.01% 1840
2014
Q2
$13.3M Buy
644,293
+101,107
+19% +$2.09M 0.01% 1770
2014
Q1
$10.5M Buy
543,186
+191,216
+54% +$3.7M ﹤0.01% 1927
2013
Q4
$8.55M Buy
351,970
+149,648
+74% +$3.63M ﹤0.01% 2077
2013
Q3
$4.35M Buy
+202,322
New +$4.35M ﹤0.01% 2572